Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Once-daily cystic fibrosis drug offers simpler home treatment and fewer side effects for children

11.02.2005


Nottingham researchers have found a way to treat children with cystic fibrosis (CF), which could reduce their side effects and see more young patients treated at home.



Experts at The University of Nottingham organised the largest successful clinical trial in the UK looking at cystic fibrosis in an attempt to discover whether a common antibiotic used to treat the condition could be administered just once a day instead of the usual three daily doses.

The recommendations from the study, which included CF patients from Nottingham City Hospital and will be published in The Lancet this week, could lead to simpler home treatment with less disruption to patients and their families.


The study was funded with £404,464 from the Cystic Fibrosis Trust, as part of their UK-wide work to improve clinical support for people with cystic fibrosis and help find a cure for this disease.

One of the patients who took part in the study was 17-year-old Kayleigh Boden. Kayleigh, an A-level student from Welton near Lincoln, found that her side effects reduced and she liked being able to administer her drugs just once a day at 4pm rather than the usual three times a day, including a midnight shift.

“The drugs usually lead to tinnitus and headaches and my eyes are affected, but I definitely suffered fewer side effects during the trial,” she added.

Kayleigh hopes that administering her drugs just once a day will help her to effectively manage her condition while allowing her to lead an active life that will include sitting her exams in the summer and, hopefully, achieving her ambition of going to university to train as a quantity surveyor.

Cystic fibrosis is the UK’s most common life-threatening inherited disease. Sufferers have difficulty in digesting food and are vulnerable to chronic chest infections. Every week five babies are born with CF and three people die from the condition — 90 per cent from the lung damage, which often results from chronic chest infections.

Patients are frequently given prolonged courses of intravenous antibiotics to treat chronic chest infections, often for two weeks or more. This treatment may be needed every few months and can interfere with children’s schooling or adults studying or getting work. Sometimes intravenous treatment is given at home rather than in hospital to make this easier. However, administering this treatment puts an extra strain on parents, partners or the patient themselves.

In an effort to make home treatment easier, the team in the University’s Division of Respiratory Medicine, led by Professor Alan Knox and Dr Alan Smyth, organised the TOPIC (Tobramycin Once-daily Prescribing In Cystic fibrosis) national trial.

The researchers are based at the study’s co-ordinating centre, Nottingham City Hospital, where they care for 80 children with CF and travel out to see another 80 children at five other hospitals. The hospital also has a busy adult clinic treating more than 100 patients.

The study looked at tobramycin, a commonly-used antibiotic, to see if it would be effective when given once a day rather than the usual three times daily treatment. The drug can potentially lead to reduced kidney function and hearing loss. However, the TOPIC team found that once daily treatment worked just as well and seemed to have fewer side effects in children.

Rosie Barnes, Chief Executive of the Cystic Fibrosis Trust, said: “This is a very encouraging and exciting piece of research not least because of the immediate impact on patients. It will help relieve what is very time-consuming care and reduce the amount of time spent taking the required dose of antibiotics.”

The team is now looking at new ways to help people with CF. Current projects are looking at the role of garlic capsules against chest infection and whether home treatment can be simplified further by giving a second antibiotic as a 24-hour infusion through a small pump device.

Dr Alan Smyth | alfa
Further information:
http://www.nottingham.ac.uk

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

NASA's Fermi catches gamma-ray flashes from tropical storms

25.04.2017 | Physics and Astronomy

Researchers invent process to make sustainable rubber, plastics

25.04.2017 | Materials Sciences

Transfecting cells gently – the LZH presents a GNOME prototype at the Labvolution 2017

25.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>